186 related articles for article (PubMed ID: 29927090)
1. P16
Tuo L; Sha S; Huayu Z; Du K
Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090
[TBL] [Abstract][Full Text] [Related]
2. Bronchial lavage P 16INK4A gene promoter methylation and lung cancer diagnosis: A meta-analysis.
Yifan D; Qun L; Yingshuang H; Xulin L; Jianjun W; Qian M; Yuman Y; Zhaoyang R
Indian J Cancer; 2015 Dec; 52 Suppl 2():e96-8. PubMed ID: 26728683
[TBL] [Abstract][Full Text] [Related]
3. APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis.
Liu F; Lu X; Zhou X; Huang H
Thorac Cancer; 2021 Nov; 12(21):2907-2913. PubMed ID: 34545707
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of serum p16 gene promoter methylation for diagnosis of nonsmall cell lung cancer.
Yan R; Chi L; Zheng X; Sun R; You J; Ye X
Indian J Cancer; 2015 Dec; 52 Suppl 2():e116-8. PubMed ID: 26728668
[TBL] [Abstract][Full Text] [Related]
5. Correlation Between RASSF1A Gene Promoter Hypermethylation in Serum or Sputum and Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis.
Zhang Z; Yan S; Cui H; Chen H; Liu J
Med Sci Monit; 2019 Jul; 25():5518-5524. PubMed ID: 31342946
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K
Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839
[TBL] [Abstract][Full Text] [Related]
7. Alterations of the p16(ink4a) gene in resected nonsmall cell lung tumors and exfoliated cells within sputum.
Chen JT; Chen YC; Wang YC; Tseng RC; Chen CY; Wang YC
Int J Cancer; 2002 Apr; 98(5):724-31. PubMed ID: 11920642
[TBL] [Abstract][Full Text] [Related]
8. MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta-analysis.
Chen B; Ying X; Bao L
Thorac Cancer; 2021 Dec; 12(23):3194-3200. PubMed ID: 34651448
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Methylation Panel in the Promoter Region of
Mohammed F; Baydaa Abed Hussein A; Ahmed T
Arch Razi Inst; 2022 Jun; 77(3):1075-1081. PubMed ID: 36618318
[TBL] [Abstract][Full Text] [Related]
10. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum.
Hulbert A; Jusue-Torres I; Stark A; Chen C; Rodgers K; Lee B; Griffin C; Yang A; Huang P; Wrangle J; Belinsky SA; Wang TH; Yang SC; Baylin SB; Brock MV; Herman JG
Clin Cancer Res; 2017 Apr; 23(8):1998-2005. PubMed ID: 27729459
[No Abstract] [Full Text] [Related]
11. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis.
Ota N; Kawakami K; Okuda T; Takehara A; Hiranuma C; Oyama K; Ota Y; Oda M; Watanabe G
Anticancer Res; 2006; 26(5B):3729-32. PubMed ID: 17094392
[TBL] [Abstract][Full Text] [Related]
13. K-ras and p16(INK4A)alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers.
Destro A; Bianchi P; Alloisio M; Laghi L; Di Gioia S; Malesci A; Cariboni U; Gribaudi G; Bulfamante G; Marchetti A; Bosari S; Infante M; Ravasi G; Roncalli M
Lung Cancer; 2004 Apr; 44(1):23-32. PubMed ID: 15013580
[TBL] [Abstract][Full Text] [Related]
14. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL
Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584
[TBL] [Abstract][Full Text] [Related]
15. Aberrant promoter methylation of p16(INK4a), RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer.
Grote HJ; Schmiemann V; Geddert H; Rohr UP; Kappes R; Gabbert HE; Böcking A
Int J Cancer; 2005 Sep; 116(5):720-5. PubMed ID: 15849750
[TBL] [Abstract][Full Text] [Related]
16. Analyses of P16
Jurisic V; Obradovic J; Nikolic N; Javorac J; Perin B; Milasin J
Mol Biol Rep; 2023 Feb; 50(2):971-979. PubMed ID: 36378420
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic Efficacy of SHOX2 Gene Hypermethylation for Lung Cancer: A Meta-Analysis].
Liu Q; Wang S; Pei G; Yang Y; Huang Y
Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):490-496. PubMed ID: 34275516
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis demonstrates no association between p16
Jiang Y; Yan F; Liang L; Wan Y; Liu J; Cheng W
Arch Gynecol Obstet; 2017 Mar; 295(3):697-704. PubMed ID: 28000027
[TBL] [Abstract][Full Text] [Related]
19. Assessing the use of p16(INK4a) promoter gene methylation in serum for detection of bladder cancer.
Valenzuela MT; Galisteo R; Zuluaga A; Villalobos M; Núñez MI; Oliver FJ; Ruiz de Almodóvar JM
Eur Urol; 2002 Dec; 42(6):622-8; discussion 628-30. PubMed ID: 12477660
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum.
Gilliland FD; Harms HJ; Crowell RE; Li YF; Willink R; Belinsky SA
Cancer Res; 2002 Apr; 62(8):2248-52. PubMed ID: 11956078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]